Analysis of host gene regulation by Epstein-Barr Virus Nuclear Antigen 3B (EBNA3B)

File Description SizeFormat 
Ho-G-2016-PhD-Thesis.pdfThesis12.45 MBAdobe PDFView/Open
Title: Analysis of host gene regulation by Epstein-Barr Virus Nuclear Antigen 3B (EBNA3B)
Authors: Ho, Guiyi
Item Type: Thesis or dissertation
Abstract: EBNA3A and EBNA3C are oncoproteins that are essential for EBV-driven transformation of B-cells, whereas in vivo studies have demonstrated that EBNA3B has tumour suppressive properties. Previous exon-microarray studies performed by our group have identified a subset of cellular genes that may be regulated by EBNA3B. In order to investigate the gene regulatory mechanisms of EBNA3B, I established a Doxycycline (Dox)-inducible EBNA3B system by transfecting EBNA3B-null (3BKO) lymphoblastoid cell lines (LCLs) with a pRTS vector expressing EBNA3B with Dox treatment. Using this system I tested 43 predicted EBNA3B-regulated genes using Taqman Low Density Array cards and confirmed that EBNA3B rapidly and robustly represses 7 genes, and induces 1 gene. I have additionally established LCLs expressing epitope (FLAG-Strep-Strep)-tagged EBNA3B and used these for Chromatin Immunoprecipitation linked to high throughput sequencing (ChIP-seq). ChIP-seq analyses uncovered 1931 EBNA3B peaks and revealed that EBNA3B localises distal to its predicted target genes, in enhancer regions that are positive for active histone marks (H3K4me1 ± H3K27Ac). EBNA3B frequently overlaps with EBNA3C, but EBNA3B-only binding sites are found within currently uncharacterised genomic regions. EBNA3B binds within the same looped chromatin domain as TERT and TNFSF10 genes, and qPCR analyses revealed that induction of EBNA3B using the Dox-inducible system robustly alters the expression of these genes. Focussed analyses revealed that EBNA3B binds to a putative enhancer 17kb upstream of the TERT promoter and strongly represses the expression of TERT, a gene encoding the catalytic subunit of the telomere-lengthening telomerase complex. EBNA3B mediates gene repression by facilitating the removal of active histone marks (H3K27Ac, H3K9Ac and H3K4me3) from the TERT promoter and EBNA3B-bound region and by recruiting Polycomb Repressive Complex to deposit repressive H3K27me3 at the TERT promoter. However, deletion of EBNA3B does not have an obvious effect on stabilising telomere lengths during the first 120 days of B-cell outgrowth.
Content Version: Open Access
Issue Date: Nov-2016
Date Awarded: Jan-2017
URI: http://hdl.handle.net/10044/1/50308
Supervisor: Allday, Martin
White, Rob
Sponsor/Funder: Singapore. Agency for Science, Technology and Research
Wellcome Trust (London, England)
Funder's Grant Number: 099273/Z/12/Z (Wellcome Trust)
Department: Faculty of Medicine
Publisher: Imperial College London
Qualification Level: Doctoral
Qualification Name: Doctor of Philosophy (PhD)
Appears in Collections:Medicine PhD theses



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commonsx